Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 69

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Summary of meta-analyses of therapies for postmenopausal osteoporosis and the relationship between bone density and fractures

Guyatt, Gordon H, Cranney, Ann, Griffith, Lauren, Walter, Stephen, Krolicki, Nicole, Favus, Murray, Rosen, Clifford·2002·Endocrinology and Metabolism Clinics of North America

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0889-8529(02)00024-5

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 26

  1. Cauley, 2000, Risk of mortality following clinical fractures, Osteoporos Int, 11, 556, 10.1007/s001980070075 · DOI · Paper page
  2. Klotzbuecher, 2000, Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis, J Bone Miner Res, 4, 721, 10.1359/jbmr.2000.15.4.721 · DOI · Paper page
  3. Lindsay, 2001, Risk of new vertebral fracture in the year following a fracture, JAMA, 285, 320, 10.1001/jama.285.3.320 · DOI · Paper page
  4. Kado, 1999, Vertebral fractures and mortality in older women, Arch Intern Med, 159, 1215, 10.1001/archinte.159.11.1215 · DOI · Paper page
  5. Cranney, 2001, A meta-analysis of etidronate for the treatment of postmenopausal osteoporosis, Osteoporos Int, 12, 140, 10.1007/s001980170147 · DOI
  6. Cranney A, Guyatt GH, Willan A, Griffith L, Krolicki N, Welch V, et al, the Osteoporosis Research Advisory Group, and the Osteoporosis Methodology Group. Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev, in press.
  7. Shea B, Guyatt G, Cranney A, Krolicki N, Welch V, Griffith L, et al, the Osteoporosis Research Advisory Group, and the Osteoporosis Methodology Group. Meta-analyses of calcium supplementation for the prevention of postmenopausal osteoporosis. Endocr Rev, in press.
  8. Papadimitropoulos E, Guyatt G, Shea B, Gillespie W, Weaver B, Krolicki N, et al, the Osteoporosis Research Advisory Group, and the Osteoporosis Methodology Group. A meta-analyses of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. Endocr Rev, in press.
  9. Cranney A, Guyatt G, Adachi J, Weaver B, Krolicki N, Papaiannou A, et al, the Osteoporosis Research Advisory Group, and the Osteoporosis Methodology Group. A meta-analyses of risedronate for the treatment of postmenopausal osteoporosis. Endocr Rev, in press.
  10. Cranney A, Guyatt G, Krolicki N, Welch V, Weaver B, Adachi J, et al, the Osteoporosis Research Advisory Group, and the Osteoporosis Methodology Group. Meta-analysis of raloxifene for the prevention and treatment of postmenopausal osteoporosis. Endocr Rev, in press.
  11. Wells G, Tugwell P, Shea B, Guyatt G, Peterson J, Krolicki N, et al, the Osteoporosis Research Advisory Group, and the Osteoporosis Methodology Group. A meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women. Endocr Rev, in press.
  12. Cranney A, Guyatt G, Krolicki N, Welch V, Weaver B, Shea B, et al, the Osteoporosis Research Advisory Group, and the Osteoporosis Methodology Group. Meta-analysis of calcitonin for the treatment of postmenopausal osteoporosis. Endocr Rev, in press.
  13. Haguenauer, 2000, Fluoride for the treatment of postmenopausal osteoporotic fractures: a meta-analysis, Osteoporos Int, 11, 727, 10.1007/s001980070051 · DOI
  14. Cranney A, Guyatt G, Griffith L, Wells G, Tugwell P, the Osteoporosis Research Advisory Group (ORAG), and the Osteoporosis Methodology Group. Summary meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev, in press.
  15. Schulz, 1995, Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials, JAMA, 273, 408, 10.1001/jama.1995.03520290060030 · DOI
  16. Guyatt, 1993, Users' guide to the medical literature, JAMA, 2598, 10.1001/jama.1993.03510210084032 · DOI · Paper page
  17. Reginster, 2000, Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis, Osteoporos Int, 11, 83, 10.1007/s001980050010 · DOI · Paper page
  18. Montori, 2001, Intention-to-treat principle, Canadian Medical Association Journal, 165, 1339
  19. Bucher, 1997, The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials, J Clin Epidemiol, 50, 683, 10.1016/S0895-4356(97)00049-8 · DOI · Paper page
  20. Seeley, 1991, For the Study of Osteoporotic Fractures. Which fractures are associated with low appendicular mass in elderly women?, Ann Intern Med, 115, 837, 10.7326/0003-4819-115-11-837 · DOI · Paper page
  21. Marshall, 1996, Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures, BMJ, 312, 1254, 10.1136/bmj.312.7041.1254 · DOI · Paper page
  22. Wasnich, 2000, Antifracture efficacy of antiresorptive agents are related to changes in bone density, J Clin Endocrinol Metab, 85, 231, 10.1210/jcem.85.1.6267 · DOI · Paper page
  23. Black DM, Pearson JB, Karpf DB, Harris F, Genant HK, LaCroix AZ. How much of the reduction in risk of vertebral fractures by alendronate is explained by increased spine BMD [abstract 1107]? Presented at the 21st Annual Meeting of the ASBMR. St. Louis (MO), September 30–October 4, 1999.
  24. Li, 2001, A method to assess the proportion of treatment effect explained by a surrogate endpoint, Stat Med, 20, 3175, 10.1002/sim.984 · DOI
  25. Chesnut, 2001, Reconsidering the effects of anti-resorptive therapies in reducing osteoporotic fracture, J Bone Miner Res, 16, 2163, 10.1359/jbmr.2001.16.12.2163 · DOI
  26. Togerson, 2001, Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials, JAMA, 285, 2891, 10.1001/jama.285.22.2891 · DOI · Paper page

Cited by

See all 69

Metadata

Authors
Guyatt, G. H., Cranney, A., Griffith, L., Walter, S., Krolicki, N., Favus, M., & Rosen, C.
Venue
Endocrinology and Metabolism Clinics of North America
Publisher
Elsevier BV
Published
2002-09
Volume
31
Issue
3
Pages
659-679
ISSN
0889-8529
Cited by
69
References
9
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.